Celiac disease and epilepsy: favorable outcome in a child with difficult to control seizures

R Pratesi1, I C Modelli, R C Martins

  • 1Department of Pediatric Neurology, Brasilia University Hospital, University of Brasilia, Brasilia DF, Brazil. riccardoop@abordo.com.br

Insights

A child with difficult-to-control epilepsy and celiac disease showed improved seizure control after starting a gluten-free diet. This case highlights the importance of screening for celiac disease in epilepsy patients.

Area of Science:

  • Pediatric Neurology
  • Gastroenterology
  • Autoimmune Disorders

Background:

  • Epilepsy, particularly Lennox-Gastaut syndrome, can be challenging to manage.
  • Celiac disease is an autoimmune disorder triggered by gluten ingestion.
  • The co-occurrence of epilepsy and celiac disease warrants further investigation.

Observation:

  • A pediatric patient presented with difficult-to-control seizures, suggestive of Lennox-Gastaut syndrome.
  • Diagnostic workup revealed celiac disease, confirmed by serological tests and jejunal biopsy.
  • The patient's seizure frequency and EEG patterns indicated a link between the conditions.

Findings:

  • Initiation of a gluten-free diet led to progressive seizure control.
  • Anti-epileptic drug dosages were significantly reduced following dietary intervention.
  • Positive anti-endomysium and anti-transglutaminase antibody tests supported the celiac diagnosis.

Implications:

  • Early diagnosis and management of celiac disease may improve epilepsy outcomes.
  • Serological screening for celiac disease should be considered in pediatric patients with refractory epilepsy.
  • This case underscores the potential impact of dietary interventions on neurological conditions.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...